The 'pink pill' flibanserin has been called 'the female Viagra', but critics argue its benefits are few and side effects many.
Melanie Abbott investigates how the failed anti-depressant came to be licensed in the USA, and what the future plans are to bring the drug to Europe.
Presenter: Melanie Abbott
Producer: James Melley
Researcher: Phoebe Keane.
